Description
SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC
Thermo Fisher Scientific
Parent Company
Thermo Fisher Scientific
Category
Precision Health Equipment
Sector
Healthcare
Tagline/ Slogan
The world Leader in serving Science
USP
Market leader in precision laboratory equipments
STP
High-end analytical instruments as well as laboratory equipment, Segment software, services, consumables and reagents
Customers within pharmaceutical and biotech companies, hospitals and Target Group clinical diagnostic labs, research based organizations
Positioning
They provide world class service & support
SWOT Analysis
1. Expected benefits related to the acquisitions of Dionex and Phadia and others 2. Introduction of Orbitrap Mass Spectrometry Platform which will Increase sales and revenue 3. Broad portfolio encompassing equipments, consumables, reagents, software required for scientific analysis 4. Over 39,000 well trained employees Strength 5. Strong financial position
1. High dependence on pharmaceutical, biotechnology institutes Weakness 2. Limited brand recall globally as compared to international players
1. Increase in revenue from emerging economies such as India, China, and South Africa. 2. Long-term growth investments, such as strategic acquisition 3. Increase the depth of capabilities in technologies, software and services, and advantage extensive global channels to address Opportunity customers’ emerging needs.
1. Its business is exposed to currency fluctuations 2. Effect of healthcare reform legislation Threats 3. Changes in governmental regulations
Competition
1. Schimadzu laboratories 2. Waters 3. Kubota equipments Competitors 4. Vertis
doc_307478326.docx
SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC
Thermo Fisher Scientific
Parent Company
Thermo Fisher Scientific
Category
Precision Health Equipment
Sector
Healthcare
Tagline/ Slogan
The world Leader in serving Science
USP
Market leader in precision laboratory equipments
STP
High-end analytical instruments as well as laboratory equipment, Segment software, services, consumables and reagents
Customers within pharmaceutical and biotech companies, hospitals and Target Group clinical diagnostic labs, research based organizations
Positioning
They provide world class service & support
SWOT Analysis
1. Expected benefits related to the acquisitions of Dionex and Phadia and others 2. Introduction of Orbitrap Mass Spectrometry Platform which will Increase sales and revenue 3. Broad portfolio encompassing equipments, consumables, reagents, software required for scientific analysis 4. Over 39,000 well trained employees Strength 5. Strong financial position
1. High dependence on pharmaceutical, biotechnology institutes Weakness 2. Limited brand recall globally as compared to international players
1. Increase in revenue from emerging economies such as India, China, and South Africa. 2. Long-term growth investments, such as strategic acquisition 3. Increase the depth of capabilities in technologies, software and services, and advantage extensive global channels to address Opportunity customers’ emerging needs.
1. Its business is exposed to currency fluctuations 2. Effect of healthcare reform legislation Threats 3. Changes in governmental regulations
Competition
1. Schimadzu laboratories 2. Waters 3. Kubota equipments Competitors 4. Vertis
doc_307478326.docx